PFB-FDG (solution)
PFB-FDG (solution) is a non-fluorescent galactosidase substrate that can be hydrolyzed into green fluorescent PFB-F (Ex=485 nm, Em=535 nm). PFB-FDG (solution) can be hydrolyzed by β-galactosidases derived from humans, bovine liver, and Aspergillus oryzae, producing a non-leakable green fluorescent product, which enables the detection of enzyme activity in liposomes and via flow cytometry. PFB-FDG (solution) is used for the determination of β-galactosidase activity.
For research use only. We do not sell to patients.
- CAS No.: 209540-64-7
- Formula: C39H32F5NO16
- Molecular Weight:865.66
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Guidelines (The following is our recommended experimental protocol. This protocol serves only as a reference guide, and specific operations should be adjusted according to your actual needs).
β-Galactosidase Activity Assay[6]:
1. Incubate 2 × 105 cells in serum-free DMEM medium containing 25 mM Hepes (pH 7.4) supplemented with 50 μg/mL PFB-FDG at 37°C for 2 h. (Taking monocytes as an example, cell concentration can be adjusted for different cell types)
2. Wash the cells once with pre-chilled PBS.
3. Analyze the cells using a flow cytometer (excitation wavelength Ex=485 nm, emission wavelength Em=535 nm).
PFB-FDG (solution) (20-40 μM; pre-incubated with conduritol B epoxide for 30 min) detects significant lysosomal GBA deficiency (residual activity is 2-4% of normal levels) in fibroblasts from LIMP2-deficient AMRF patients, while significant residual GBA activity is detected in lymphocytes (35% of normal levels), monocytes (47% of normal levels), and monocyte-derived macrophages (32% of normal levels) from AMRF patients[5].
PFB-FDG (solution) (3 h) is a non-leaky fluorescent substrate that can be used to detect functional β-galactosidase synthesized inside POPC/cholesterol/DSPE-PEG5000 liposomes. Enzyme activity is determined by measuring green fluorescence via flow cytometry (FACS) after incubation at 37°C for 3 h[1].
PFB-FDG (solution) enables the detection of senescence-associated β-galactosidase activity via hydrolysis. Results show that senescence-associated β-galactosidase activity is significantly higher in freshly isolated human CD34+ CD133+ hematopoietic progenitor cells from middle-aged donors than in those from young donors[2].
PFB-FDG (solution) (2 h) can be activated by endogenous SA-β-gal in viable human U251.JMJD3wt glioma cells, generating detectable green fluorescence after incubation at a concentration of 3 mg/mL for 2 h[3].
PFB-FDG (solution) (50 μM; overnight) is a viable fluorescent substrate for the β-galactosidase reaction inside microfluidics-derived GUVs. It undergoes efficient hydrolysis during overnight incubation at 37 °C, while the size of GUVs remains stable[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 209540-64-7
-
Molecular Weight 865.66
-
Formula C39H32F5NO16
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[2]. Navarrete Santos A, et al. Evidences for age-related modulation of human hematopoietic progenitor cell proliferation. Experimental gerontology. 2008 Nov;43(11):1033-8. [Content Brief]
[6]. Navarrete Santos A, et al. Evidences for age-related modulation of human hematopoietic progenitor cell proliferation. Exp Gerontol. 2008 Nov;43(11):1033-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)